Volume | 2,205 |
|
|||||
News | - | ||||||
Day High | 0.8229 | Low High |
|||||
Day Low | 0.81 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
YS Biopharma Company Ltd | YS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.8229 | 0.81 | 0.8229 | 0.8109 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8 | 2,205 | $ 0.8159483 | $ 1,799 | - | 0.3503 - 1.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:34:49 | 45 | $ 0.809 | USD |
YS Biopharma Company Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.44M | 93.06M | - | 687.2M | -283.47M | -3.05 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
YS Biopharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.84 | 0.96 | 0.70 | 0.8300602 | 266,677 | -0.03 | -3.57% |
1 Month | 0.6352 | 1.0285 | 0.6017 | 0.8393541 | 182,199 | 0.1748 | 27.52% |
3 Months | 0.455 | 1.0285 | 0.3503 | 0.5916384 | 225,944 | 0.355 | 78.02% |
6 Months | 0.6101 | 1.0285 | 0.3503 | 0.5600591 | 164,835 | 0.1999 | 32.77% |
1 Year | 1.61 | 1.97 | 0.3503 | 1.21 | 512,338 | -0.80 | -49.69% |
3 Years | 12.67 | 12.93 | 0.3503 | 1.40 | 587,127 | -11.86 | -93.61% |
5 Years | 12.67 | 12.93 | 0.3503 | 1.40 | 587,127 | -11.86 | -93.61% |
YS Biopharma Description
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. |